Pictet Asset Management Holding SA »

BioCryst Pharmaceuticals shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $100k 20k 5.08

More positions owned by Pictet Asset Management Holding SA

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Amazon (AMZN)
Republic Services (RSG)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Meta Platforms Cl A (META)
Waste Connections (WCN)
Synopsys (SNPS)
Applied Materials (AMAT)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Xylem (XYL)

View all positions for Pictet Asset Management Holding SA

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
venBio Select Advisor
Baker Bros. Advisors
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
Alkeon Capital Management
RP Management
Rock Springs Capital Management
Jennifer Ranahan
Braidwell
Fisher Investments
Nuveen Asset Management

View all funds holding BioCryst Pharmaceuticals